Anti-cancer tech may also turn back time
One day, an mTOR inhibitor drug may be both a fountain of youth and a pot of gold. For now, an ASX firm is using the tech to fight cancer. PharmAus (ASX:PAA) is developing its lead drug, monepantel (MPL) to treat cancer growth and neurodegenerative diseases such as motor neurone disease (MND). But the prospects … [Read more…]
